Neurogene Inc. (NGNE) Operating income 2016–2025
Neurogene Inc. (NGNE) annual operating income history from SEC filings — each fiscal year as reported.
-$103.3MFY2025 · since FY2016: -$37.6M → -$103.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$103.3M | -25.1% |
| FY2024 | -$82.6M | -48.6% |
| FY2023 | -$55.6M | +1.7% |
| FY2022 | -$56.5M | +6.9% |
| FY2021 | -$60.7M | -80.0% |
| FY2020 | -$33.7M | +52.5% |
| FY2019 | -$71.0M | -117.5% |
| FY2018 | -$32.6M | +36.2% |
| FY2017 | -$51.1M | -35.8% |
| FY2016 | -$37.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice